Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hypoxia01:23

Hypoxia

2.7K
Hypoxia is a medical condition characterized by an inadequate oxygen supply to body tissues. It typically manifests as a bluish discoloration of the skin and mucosae, especially in fair-skinned individuals, when hemoglobin (Hb) saturation drops below 75%.
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
2.7K
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

7.3K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
7.3K
Necrosis01:16

Necrosis

7.5K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
7.5K
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

1.7K
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.7K
Peroxisomes01:24

Peroxisomes

22.3K
Peroxisomes are specialized organelles present in fungi, plant, and animal cells. It can vary in number, size, morphology, and activity depending on the type of tissue and the nutritional state of the cell. For example, cells with active lipid metabolism, such as adipocytes, neurons, and hepatocytes, have more peroxisomes than other cells in the body. Besides their primary role in breaking down complex organic molecules, peroxisomes can also synthesize specific macromolecules and participate in...
22.3K
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

24
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to...
24

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of Tissue Adequacy by Computed Tomography-Guided Needle Biopsy for Comprehensive Genomic Profiling Following Chemotherapy.

Cureus·2026
Same author

Cholecystitis and Liver Abscess Caused by Oral Bacteria.

Cureus·2026
Same author

Feasibility and Short-Term Outcomes of an endoCUT-Based Non-Ligation Cervical Conization Strategy: A Single-Center Retrospective Study.

The journal of obstetrics and gynaecology research·2026
Same author

Potential stratification of TAFRO syndrome by anti-SS-A antibodies status and therapeutic response to rituximab.

RMD open·2026
Same author

The complete mitochondrial genome sequence of the saprotrophic filamentous fungus <i>Umbelopsis nana</i>.

Mitochondrial DNA. Part B, Resources·2026
Same author

Successful Treatment of Overlapping Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease and Glial Fibrillary Acidic Protein Astrocytopathy With Plasma Exchange.

Journal of medical cases·2026

Related Experiment Video

Updated: Apr 21, 2026

Mechanism of Regulation of Adipocyte Numbers in Adult Organisms Through Differentiation and Apoptosis Homeostasis
08:34

Mechanism of Regulation of Adipocyte Numbers in Adult Organisms Through Differentiation and Apoptosis Homeostasis

Published on: June 3, 2016

15.9K

Hypoxia and fatty liver.

Tomohiro Suzuki1, Satoko Shinjo1, Takatomo Arai1

  • 1Tomohiro Suzuki, Satoko Shinjo, Takatomo Arai, Mai Kanai, Nobuhito Goda, Department of Life Science and Medical BioScience, Waseda University School of Advanced Science and Engineering, Tokyo 162-8480, Japan.

World Journal of Gastroenterology
|November 12, 2014
PubMed
Summary

Hypoxia-inducible factors (HIFs) are key regulators of lipid metabolism, influencing fatty liver disease development. This review explores how hypoxia and HIFs impact lipid metabolism in fatty liver disease progression.

Keywords:
Fatty liver diseaseHypoxiaHypoxia-inducible factorLipid metabolismObstructive sleep apnea

More Related Videos

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
08:58

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis

Published on: March 11, 2017

17.2K
Determination of Fatty Acid Oxidation and Lipogenesis in Mouse Primary Hepatocytes
12:11

Determination of Fatty Acid Oxidation and Lipogenesis in Mouse Primary Hepatocytes

Published on: August 27, 2015

20.9K

Related Experiment Videos

Last Updated: Apr 21, 2026

Mechanism of Regulation of Adipocyte Numbers in Adult Organisms Through Differentiation and Apoptosis Homeostasis
08:34

Mechanism of Regulation of Adipocyte Numbers in Adult Organisms Through Differentiation and Apoptosis Homeostasis

Published on: June 3, 2016

15.9K
Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
08:58

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis

Published on: March 11, 2017

17.2K
Determination of Fatty Acid Oxidation and Lipogenesis in Mouse Primary Hepatocytes
12:11

Determination of Fatty Acid Oxidation and Lipogenesis in Mouse Primary Hepatocytes

Published on: August 27, 2015

20.9K

Area of Science:

  • Hepatology and metabolic research
  • Molecular mechanisms of liver disease

Background:

  • The liver's metabolic functions create steep oxygen gradients, making it susceptible to metabolic imbalances from alcohol or overnutrition.
  • Fatty liver disease, encompassing steatosis to cirrhosis, disrupts oxygen homeostasis, leading to severe liver hypoxia.
  • Hypoxia-inducible factors (HIFs) are critical regulators of cellular adaptation to low oxygen conditions.

Purpose of the Study:

  • To review the molecular mechanisms by which hypoxia and HIFs regulate lipid metabolism.
  • To elucidate the role of HIFs in the development and progression of fatty liver disease.

Main Methods:

  • Literature review of studies on hypoxia, HIFs, and lipid metabolism in the context of fatty liver disease.

Main Results:

  • HIFs are increasingly recognized as key factors in regulating lipid metabolism.
  • Hypoxia and HIFs significantly influence the development and progression of fatty liver disease through various molecular pathways.

Conclusions:

  • Understanding the interplay between hypoxia, HIFs, and lipid metabolism is crucial for addressing fatty liver disease.
  • Targeting HIF pathways may offer therapeutic strategies for managing fatty liver disease.